Protheragen Rare Disease specializes in providing a range of preclinical research services for rare disease research, addressing many of the challenges encountered in drug discovery and development. Its end-to-end rare disease therapy development solutions cover a full package of therapeutic development services, which include small molecule, cell therapy, gene therapy, therapeutic antibody, therapeutic peptide, and therapeutic protein. These services and solutions are committed to expanding scientific understanding and finding new therapies for rare diseases that often lack attention and resources.